Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

FTC issues policy condemning the improper listing of patents in FDA’s Orange Book

The Federal Trade Commission voted 3-0 on Thursday to issue a policy statement to increase scrutiny of improper listing of patents in the FDA’s Orange

September 15, 2023

Interdisciplinary project aims to revolutionize health care data integration

Health care is more than doctor visits; it’s a team effort. But most artificial intelligence-driven technologies built on patient data use only the information provided

October 1, 2024

Embolization Proves Its Mettle for Subdural Hematoma

PHOENIX — For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.